You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDX-1140

Showing 51 - 64 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Prostate Cancer Trial in Charlottesville (CDX1127, SBRT)

Terminated
  • Prostatic Neoplasms
  • Prostate Cancer
  • CDX1127
  • SBRT
  • Charlottesville, Virginia
    University of Virginia
May 16, 2018

CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in

Completed
  • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
  • +9 more
  • Scottsdale, Arizona
  • +9 more
Jan 29, 2018

Malignant Glioma Trial in United States (CDX-110 with GM-CSF, Temozolomide)

Completed
  • Malignant Glioma
  • Orange, California
  • +33 more
Jan 11, 2018

NSCLC Trial in New Haven (CDX-1401, MPDL3280A)

Withdrawn
  • Non-Small Cell Lung Cancer
  • New Haven, Connecticut
    Yale University
Jun 21, 2017

Healthy Trial in New York (CDX-301)

Completed
  • Healthy
  • New York, New York
    Rockefeller University
Jun 26, 2017

Breast Cancer Trial in United States (CDX-011, "Investigator's Choice" chemo)

Completed
  • Breast Cancer
  • CDX-011
  • "Investigator's Choice" chemotherapy
  • Birmingham, Alabama
  • +23 more
Jun 26, 2017

Unresectable Stage III or Stage IV Melanoma Trial in United States (Combination of varlilumab and ipilimumab, Cohort A:

Terminated
  • Unresectable Stage III or Stage IV Melanoma
  • Combination of varlilumab and ipilimumab
  • Cohort A: varlilumab & ipilimumab; Cohort B: varlilumab, ipilimumab, CDX-1401 & poly-ICLC
  • San Francisco, California
  • +7 more
Apr 6, 2017

For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States

Terminated
  • For Donors
  • +9 more
  • Los Angeles, California
  • +7 more
Apr 6, 2017

Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,

Withdrawn
  • Non Small Cell Lung Cancer
  • +5 more
  • (no location specified)
Dec 5, 2016

Advanced Malignancies Trial in United States (CDX-1401 in combination with Resiquimod and/or Poly-ICLC, CDX-1401, Resiquimod)

Completed
  • Advanced Malignancies
  • CDX-1401 in combination with Resiquimod and/or Poly-ICLC
  • +3 more
  • New Haven, Connecticut
  • +6 more
Jun 22, 2016

Dense Deposit Disease, Membranoproliferative Glomerulonephritis Type II, C3 Glomerulonephritis Trial in Iowa City (CDX-1135)

Terminated
  • Dense Deposit Disease
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Mar 6, 2014

Predictive of Barrett's Esophagus

Completed
  • Barrett's Esophagus
    • Boston, Massachusetts
    • +5 more
    Dec 5, 2011

    Breast Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Detroit, Durham, Huntersville (CDX1307)

    Completed
    • Breast Cancer
    • +4 more
    • CDX1307
    • Detroit, Michigan
    • +2 more
    Jul 23, 2010

    Breast Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Detroit, Durham, Huntersville (CDX-1307)

    Completed
    • Breast Cancer
    • +4 more
    • CDX-1307
    • Detroit, Michigan
    • +2 more
    Jul 23, 2010